Pertussis toxin lesions of the rat substantia nigra block the inhibitory effects of the gamma-hydroxybutyrate agent S(-)HA-966 without affecting the basal firing properties of dopamine neurons

Citation
Pd. Shepard et St. Connelly, Pertussis toxin lesions of the rat substantia nigra block the inhibitory effects of the gamma-hydroxybutyrate agent S(-)HA-966 without affecting the basal firing properties of dopamine neurons, NEUROPSYCH, 21(5), 1999, pp. 650-661
Citations number
47
Categorie Soggetti
Neurosciences & Behavoir
Journal title
NEUROPSYCHOPHARMACOLOGY
ISSN journal
0893133X → ACNP
Volume
21
Issue
5
Year of publication
1999
Pages
650 - 661
Database
ISI
SICI code
0893-133X(199911)21:5<650:PTLOTR>2.0.ZU;2-3
Abstract
S(-)3-amino-1-hydroxypyrrolidone-2 (S(-)HA-966), a potent gamma-hydroxybuty rate-like drug, inhibits spontaneous firing and induces a pacemaker-like di scharge pattern in nigral dopamine (DA)-containing neurons. Recent evidence has suggested that these effects could be mediated by GABA(B) receptors an d, thus, is likely to involve G protein intermediaries. To test this hypoth esis, extracellular single-unit recording techniques were used to assess th e effects of S(-)HA-966 in animals that had received an intranigral injecti on of pertussis toxin (PT). Failure to respond to the inhibitory effects of apomorphine was taken as presumptive evidence that PT-sensitive G protein- coupled receptors had been inactivated. No significant differences were obs erved in the basal firing properties of DA cells recorded in control and PT -lesioned animals. However, in marked contrast to the inhibitory effects ob served in uninjected and sham-lesioned animals, S(-)HA-966 significantly in creased the firing rate of apomorphine-insensitive DA neurons in PT-lesione d mts, The excitatory effects of S(-)HA-966 were accompanied by a significa nt reduction in bursting activity and an increase in the regularity of firi ng. These data indicate that the inhibitory effects of S(-)HA-966 are media ted locally within the substantia nigra by a PT-sensitive substrate, presum ably a G protein-coupled receptor. [Neuropsychopharmacology 21:650-661, 199 9] (C) 1999 American College of Neuropsychopharmacology. Published by Elsev ier Science Inc.